• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

15例接受雄激素性脱发新治疗方案患者的初步研究:特应性对雄激素性脱发的影响

Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA.

作者信息

Rafi A W, Katz R M

机构信息

HAIR CYNR-G, INC., 11500 West Olympic Boulevard, No. 630, Los Angeles, CA 90064, USA.

出版信息

ISRN Dermatol. 2011;2011:241953. doi: 10.5402/2011/241953. Epub 2011 Apr 11.

DOI:10.5402/2011/241953
PMID:22363845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3262531/
Abstract

Background. We examined the efficacy of a new regimen to treat AGA, with attention to male patients who are atopic. Objective. To assess the efficacy of a four-part regimen for the treatment of AGA in atopic and nonatopic patients. NuH Hair is a novel topical combination of finasteride, dutasteride, and minoxidil, which is blended in a hypoallergenic lotion. The other three components included Rogaine foam, Propecia, and ketoconazole shampoo. Methods. A prospective pilot study was conducted in 15 patients. All patients were assessed for the presence of atopy. Each patient served as their own control. All patients were treated specifically with NuH Hair and were given the option to add any of the other components of the protocol to their regimen. Photographs were taken of each patient's scalp at months 0, 1, 3, 6, and 9. Results. All 15 patients demonstrated significant growth of hair. In those patients who utilized all 4 components, significant growth was achieved in as little as 30 days. In those patients who choose only to utilize NuH Hair, significant growth was demonstrated after 3 months. Conclusion. Aggressively treating AGA achieves significant and rapid growth of new hair. This is effective in atopic and nonatopic male patients.

摘要

背景。我们研究了一种治疗雄激素性脱发(AGA)的新方案的疗效,特别关注特应性男性患者。目的。评估一种四部分方案对特应性和非特应性患者治疗AGA的疗效。NuH Hair是一种新型的非那雄胺、度他雄胺和米诺地尔的局部组合,混合在一种低过敏性乳液中。其他三个成分包括落健泡沫、保法止和酮康唑洗发水。方法。对15名患者进行了一项前瞻性试点研究。评估所有患者是否存在特应性。每个患者都作为自己的对照。所有患者均接受NuH Hair的专门治疗,并可选择在其治疗方案中添加该方案的任何其他成分。在第0、1、3、6和9个月拍摄每位患者头皮的照片。结果。所有15名患者均显示出显著的头发生长。在使用所有4种成分的患者中,短短30天就实现了显著生长。在那些只选择使用NuH Hair的患者中,3个月后显示出显著生长。结论。积极治疗AGA可实现新头发的显著快速生长。这对特应性和非特应性男性患者均有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/5a6975471a7b/DERMATOLOGY2011-241953.017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/2c8fc5de2c8e/DERMATOLOGY2011-241953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/4177d65f13fc/DERMATOLOGY2011-241953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/5314833b4607/DERMATOLOGY2011-241953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/1a2b30d9247a/DERMATOLOGY2011-241953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/89212dc891a5/DERMATOLOGY2011-241953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/8ff1ba4fdef6/DERMATOLOGY2011-241953.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/03bc02d3a694/DERMATOLOGY2011-241953.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/fb76bc5eadfc/DERMATOLOGY2011-241953.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/373f999bb049/DERMATOLOGY2011-241953.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/193e371bfe85/DERMATOLOGY2011-241953.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/7a7e2a53bf0f/DERMATOLOGY2011-241953.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/b77153c10017/DERMATOLOGY2011-241953.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/3552484db86f/DERMATOLOGY2011-241953.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/689f3a701812/DERMATOLOGY2011-241953.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/747e0a28fd1a/DERMATOLOGY2011-241953.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/d7fbcc6680b8/DERMATOLOGY2011-241953.016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/5a6975471a7b/DERMATOLOGY2011-241953.017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/2c8fc5de2c8e/DERMATOLOGY2011-241953.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/4177d65f13fc/DERMATOLOGY2011-241953.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/5314833b4607/DERMATOLOGY2011-241953.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/1a2b30d9247a/DERMATOLOGY2011-241953.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/89212dc891a5/DERMATOLOGY2011-241953.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/8ff1ba4fdef6/DERMATOLOGY2011-241953.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/03bc02d3a694/DERMATOLOGY2011-241953.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/fb76bc5eadfc/DERMATOLOGY2011-241953.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/373f999bb049/DERMATOLOGY2011-241953.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/193e371bfe85/DERMATOLOGY2011-241953.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/7a7e2a53bf0f/DERMATOLOGY2011-241953.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/b77153c10017/DERMATOLOGY2011-241953.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/3552484db86f/DERMATOLOGY2011-241953.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/689f3a701812/DERMATOLOGY2011-241953.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/747e0a28fd1a/DERMATOLOGY2011-241953.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/d7fbcc6680b8/DERMATOLOGY2011-241953.016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cc/3262531/5a6975471a7b/DERMATOLOGY2011-241953.017.jpg

相似文献

1
Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA.15例接受雄激素性脱发新治疗方案患者的初步研究:特应性对雄激素性脱发的影响
ISRN Dermatol. 2011;2011:241953. doi: 10.5402/2011/241953. Epub 2011 Apr 11.
2
Comparative efficacy of various treatment regimens for androgenetic alopecia in men.男性雄激素性脱发各种治疗方案的疗效比较
J Dermatol. 2002 Aug;29(8):489-98. doi: 10.1111/j.1346-8138.2002.tb00314.x.
3
Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride.含非那雄胺的外用米诺地尔:停用口服非那雄胺后维持头发密度的情况报告
Indian Dermatol Online J. 2015 Jan-Feb;6(1):17-20. doi: 10.4103/2229-5178.148925.
4
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.一种局部复方制剂治疗男性雄激素性脱发的临床疗效:10%米诺地尔、0.1%非那雄胺、0.2%生物素和0.05%柠檬酸咖啡因水醇溶液
Int J Pharm Compd. 2020 Jan-Feb;24(1):69-76.
5
Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia.5%米诺地尔泡沫联合植物性生发液治疗男性雄激素性脱发的疗效与安全性
J Drugs Dermatol. 2016 Apr;15(4):406-12.
6
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy.富含血小板血浆治疗雄激素性脱发与米诺地尔、非那雄胺和基于成人干细胞的治疗的系统评价。
Int J Mol Sci. 2020 Apr 13;21(8):2702. doi: 10.3390/ijms21082702.
7
Promising therapies for treating and/or preventing androgenic alopecia.用于治疗和/或预防雄激素性脱发的有前景的疗法。
Skin Therapy Lett. 2012 Jun;17(6):1-4.
8
Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.2017年西班牙皮肤科医生治疗雄激素性脱发的处方习惯:一项横断面研究
Actas Dermosifiliogr (Engl Ed). 2018 Jul-Aug;109(6):536-542. doi: 10.1016/j.ad.2018.02.006. Epub 2018 Apr 12.
9
Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study.度他雄胺与非那雄胺治疗韩国男性雄激素性脱发患者的长期有效性和安全性:一项多中心病历回顾研究
Ann Dermatol. 2022 Oct;34(5):349-359. doi: 10.5021/ad.22.027.
10
Androgenetic alopecia: an evidence-based treatment update.雄激素性脱发:基于证据的治疗更新。
Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5.

引用本文的文献

1
Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women.外用非那雄胺:男性和女性雄激素性脱发治疗的综合综述
Cureus. 2023 Sep 9;15(9):e44949. doi: 10.7759/cureus.44949. eCollection 2023 Sep.
2
Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia: A Pilot, Randomized Open-Label Study.外用非那雄胺(0.25%)联合米诺地尔(5%)与单独使用5%米诺地尔或0.25%非那雄胺治疗男性雄激素性脱发的疗效比较:一项前瞻性、随机开放标签研究。
Int J Trichology. 2023 Mar-Apr;15(2):56-62. doi: 10.4103/ijt.ijt_72_22. Epub 2023 Jul 28.
3

本文引用的文献

1
Controversy: is there a role for adjuvants in the management of male pattern hair loss?争议:辅助剂在男性型脱发管理中是否有作用?
J Cutan Aesthet Surg. 2010 May;3(2):82-6. doi: 10.4103/0974-2077.69016.
2
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.非那雄胺治疗雄激素性脱发的疗效与安全性:一项系统评价。
Arch Dermatol. 2010 Oct;146(10):1141-50. doi: 10.1001/archdermatol.2010.256.
3
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
雄激素性脱发的治疗选择:疗效、副作用、依从性、经济考虑因素和伦理问题。
J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6.
4
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.非那雄胺局部治疗男性和女性雄激素性脱发的系统评价
J Drugs Dermatol. 2018 Apr 1;17(4):457-463.
5
Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice.局部用酮康唑、米诺地尔以及米诺地尔与维甲酸联用对雄性小鼠毛发生长的促进作用
ISRN Pharmacol. 2014 Mar 9;2014:575423. doi: 10.1155/2014/575423. eCollection 2014.
6
Female pattern alopecia: current perspectives.女性型脱发:当前观点
Int J Womens Health. 2013 Aug 29;5:541-56. doi: 10.2147/IJWH.S49337.
每日口服 0.5 毫克度他雄胺治疗男性型脱发男性患者的疗效、安全性和耐受性:一项随机、双盲、安慰剂对照、III 期研究。
J Am Acad Dermatol. 2010 Aug;63(2):252-8. doi: 10.1016/j.jaad.2009.09.018. Epub 2010 Jun 3.
4
The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride.REDUCE试验:使用双重5α还原酶抑制剂度他雄胺进行前列腺癌化学预防
Expert Rev Anticancer Ther. 2008 Jul;8(7):1073-9. doi: 10.1586/14737140.8.7.1073.
5
[The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].[前列腺癌预防试验(PCPT)。对临床实践的相关性]
Urologe A. 2007 Oct;46(10):1364, 1366-8, 1370. doi: 10.1007/s00120-007-1553-9.
6
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.双重5α-还原酶抑制在治疗男性型脱发中的重要性:度他雄胺与非那雄胺随机安慰剂对照研究的结果
J Am Acad Dermatol. 2006 Dec;55(6):1014-23. doi: 10.1016/j.jaad.2006.05.007.
7
Topical application of ketoconazole stimulates hair growth in C3H/HeN mice.酮康唑局部应用可刺激C3H/HeN小鼠毛发生长。
J Dermatol. 2005 Apr;32(4):243-7. doi: 10.1111/j.1346-8138.2005.tb00756.x.
8
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.双重5α-还原酶抑制剂度他雄胺可显著抑制良性前列腺增生男性体内的双氢睾酮。
J Clin Endocrinol Metab. 2004 May;89(5):2179-84. doi: 10.1210/jc.2003-030330.
9
Androgenetic alopecia: pathogenesis and potential for therapy.雄激素性脱发:发病机制与治疗潜力
Expert Rev Mol Med. 2002 Nov 19;4(22):1-11. doi: 10.1017/S1462399402005112.
10
Association between smoking and hair loss: another opportunity for health education against smoking?吸烟与脱发之间的关联:这是开展控烟健康教育的又一契机?
Dermatology. 2003;206(3):189-91. doi: 10.1159/000068894.